About OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA
OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA is a rare disease catalogued by Orphanet (ORPHA:309139). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA trials.
Search ClinicalTrials.gov for "OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA" or Orphanet code ORPHA:309139 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA. Updated daily.